According to a research review, two types of oxygen therapy could offer some relief to adults who suffer from disabling migraines and cluster headaches.
Migraines are severely painful and usually occur with other symptoms such as nausea, vomiting and painful sensitivity to light. Cluster headaches cause sharp, burning pain on one side of the head.
Physicians commonly rely on a number of drug therapies to both treat and prevent migraines and cluster headaches, but some also prescribe oxygen therapy. The aim of the systematic review, comprising nine small studies involving 201 participants, was to determine whether inhaling oxygen actually helps.
"We wanted to locate and assess any evidence from randomized trials that oxygen administration was a safe and effective treatment for migraines or cluster headaches," said lead reviewer Michael Bennett. "We hoped this would assist physicians to make effective treatment decisions in this area."
The reviewers examined studies that evaluated normobaric oxygen therapy and hyperbaric oxygen therapy. Normobaric therapy consists of patients inhaling pure oxygen at normal room pressure, and hyperbaric therapy involves patients breathing oxygen at higher pressure in a specially designed chamber.
Five studies compared hyperbaric versus sham (placebo) therapy for migraines; two compared hyperbaric versus sham therapy for cluster headache; and two investigated the use of normobaric therapy for cluster headache. Length of treatment varied with each study.
Three studies reported the number of patients who had significant relief from their migraines within 40 to 45 minutes of hyperbaric therapy. Although the studies did not specify each patients' response to treatment, they reported a significant increase in the proportion of patients who had relief with hyperbaric oxygen compared to sham therapy.
For cluster headaches, two studies (69 patients) found a significantly greater proportion of patients had relief of their headaches after 15 minutes of normobaric compared to sham therapy.
The reviewers concluded that hyperbaric treatment might give some relief for migraines and that normobaric therapy might provide similar relief for cluster headaches, but there is no evidence that these therapies will prevent future attacks.
"We believe that hyperbaric oxygen is also a reasonable measure for migraineurs who have not responded to other measures to treat an acute attack," Bennett said. "However, the poor availability of hyperbaric chambers makes this an option only in a minority of health facilities."
Estimates indicate that 6 percent to 7 percent of men and 15 percent to 18 percent of women suffer from severe migraines, and cluster headaches effect about 0.2 percent of the population.
References:
1. Bennett MH, et al. Normobaric and hyperbaric oxygen therapy for migraine and cluster headache. Cochrane Database of Systematic Reviews 2008, Issue 3.
Addiction



